,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
looks like enhertu is the 'winner' of the asco breast cancer sweepstakes. 
Breast cancer specialist and professor @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. COI disclosure: no COI.